Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled date : 2022 - 02 - 22 save search
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2021 Financial Results and Business Update
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
RIGL | $1.13 -1.74% -1.77% 750K
|
Health Technology
|
| O: -2.07%
H: 3.6%
C: 0.0%
financial results conference report results
Lilly Pumps $700M into Boston-Based RNA Therapeutics Facility
Published: 2022-02-22 (Crawled : 14:30) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
therapeutics
Benign Prostatic Hyperplasia Therapeutics Market to Reach $9.39 Bn, Globally, by 2030 at 5.0% CAGR: Allied Market Research
Published: 2022-02-22 (Crawled : 13:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -0.57%
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: 1.84%
H: 0.49%
C: 0.09%
TEVA | $13.09 -1.06% 0.08% 8M
|
Health Technology
|
| O: -0.61%
H: 1.05%
C: -0.86%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -0.93%
H: 0.77%
C: 0.12%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.21%
H: 2.39%
C: 0.83%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -1.26%
H: 0.81%
C: 0.46%
research therapeutics
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Published: 2022-02-22 (Crawled : 12:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
ARE | $116.99 -1.84% 0.0% 780K
|
Finance
|
| O: 0.02%
H: 1.43%
C: 1.05%
genetic ces
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company
Published: 2022-02-22 (Crawled : 10:00) - prnewswire.com
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
treatment therapeutics diabetes
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.